GordonMD Global Investments LP: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 2039349) · Explore on the interactive board
GordonMD Global Investments LP disclosed 16 US equity positions worth $206.7m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is KYTX at 18.3% of the reported book, followed by PYXS, TSHA. The top ten holdings are 83.9% of the book, and the portfolio behaves like about 10 equal-weight positions. Versus the prior filing it opened 1 new position, added to 4, reduced 2 and exited 1. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does GordonMD Global Investments LP own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 1 new, 4 added, 2 reduced, 1 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | KYTX KYVERNA THERAPEUTICS INC | 18.3% | $37.8m | 4,244,818 | 0% | held | |
| 2 | PYXS PYXIS ONCOLOGY INC | 14.6% | $30.2m | 10,024,909 | 143% | added | |
| 3 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 11.9% | $24.5m | 723,185 | -2% | reduced |
| 4 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.9% | $16.4m | 2,402,495 | 91% | added |
| 5 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 6.7% | $13.8m | 1,353,552 | -11% | reduced |
| 6 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 5.3% | $11.0m | 5,298,000 | 270% | added |
| 7 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 5.0% | $10.4m | 279,720 | 64% | added |
| 8 | EDIT EDITAS MEDICINE INC | Healthcare | 4.9% | $10.1m | 3,127,000 | – | new |
| 9 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 4.7% | $9.7m | 289,101 | 0% | held |
| 10 | BLCO BAUSCH PLUS LOMB CORP | Healthcare | 4.6% | $9.5m | 573,472 | 0% | held |
| 11 | AMGN AMGEN INC | Healthcare | 3.5% | $7.3m | 20,212 | 0% | held |
| 12 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 3.5% | $7.3m | 132,500 | 0% | held |
| 13 | SION SIONNA THERAPEUTICS INC | Healthcare | 2.9% | $6.0m | 136,000 | 0% | held |
| 14 | INCY INCYTE CORP | Healthcare | 2.4% | $4.9m | 43,300 | 0% | held |
| 15 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 2.3% | $4.8m | 126,985 | 0% | held | |
| 16 | INSM INSMED INC | Healthcare | 1.5% | $3.0m | 28,587 | 0% | held |
What did GordonMD Global Investments LP sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| TARS TARSUS PHARMACEUTICALS INC | 100.0% | $3.0m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 64.8% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is GordonMD Global Investments LP's portfolio?
Across every quarter GordonMD Global Investments LP has filed, its median largest position is 21.9% of the book and its median top-ten weight is 83.2%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 1.0 completed holding spells, the median lasted 1.0 quarters; 16.0 positions are still open and their final length is unknown.